The role of antibodies to DNA in systemic lupus erythematosus— A review and introduction to an international workshop on DNA antibodies held in London,May 1996
Restricted accessReview articleFirst published online March, 1997
The role of antibodies to DNA in systemic lupus erythematosus— A review and introduction to an international workshop on DNA antibodies held in London,May 1996
Cepellini R. , Polli E., Celada F.A DNA-reacting factor in serum of a patient with lupus erythematosus diffuses. Proc Soc Exp Biol Med1957; 76: 572-574.
2.
Meischer P., Strassie R.New serological methods for the detection of the LE factor. Vox Sanguins1957; 2: 283.
3.
Robbins WC, Holman HR, Deicher H., Kunkel HGComplement fixation with cell nuclei and DNA in lupus erythematosus. Proc Soc Miol Med1957; 96: 575—579.
4.
Seligmann M.Mise en evidence dans le serum des malades atteints de lupus erythmateux disseminé de precipitation avec l'acide desoxyribonucleique . Comptes Rendus de l'Academie des Sciences ( Paris) 1957; 245: 243-245.
5.
Cervera R. et al. Systemic lupus erythematosus: clinical and immunolgic patterns of disease expression in a cohort of 1000 patients. Medicine (Baltimore)1993; 72: 113-124.
6.
Duncan R., McConkey EHHow many proteins are there in a typical mammalian cell?. Clin Chem1982; 28: 749-755.
7.
Gharavi AE, Chu JL, Elkon KBAutoantibodies to intra-cellular proteins in human systemic lupus erythematosus are not due to random polyclonal B cell activation. Arthritis Rheum1988; 11: 1337-1345.
8.
Swaak Ajg, Aarden LA, Statuis van Eps LW, Feltkamp TEW. Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum1979; 22: 226-235.
9.
Lloyd W., Schur PHImmune complexes, complement and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine (Baltimore)1981; 60: 208-217.
10.
Ter Borg EJ et al. Measurements of increases in anti-double stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. Arthritis Rheum1990; 33: 634-643.
11.
Okamura M. et al. Significance of enzyme linked immunosorbent assay [ELISA] for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology. Ann Rheum Dis1993; 52: 14-20.
12.
Bootsma H. et al. Prevention of relapses in systemic lupus erythematosus. Lancet1995; 345: 1595-1599.
13.
Isenberg DA , Garton M., Reichlin MW, Reichlin M.Long term follow up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients. Brit J Rheum In press.
14.
Koffler D., Schur PH, Kunkel HGImmunological studies concerning the nephritis of systemic lupus erythematosus . J Exp Med1967; 126: 607-624.
15.
Pankewycz OG , Migliorini P., Madaio MPPolreactive autoantibodies are nephritogenic in murine lupus nephritis. J Immunol1987; 139: 3287-3294.
16.
Isenberg DA et al. Detection of cross-reactive anti-DNA antibody idiotypes in the serum of lupus patients and their relatives. Arthritis Rheum1985; 28: 999-1007.
17.
Andrezewski C. et al. Antigen binding diversity and idiotypic cross-reactions among hybridoma antibodies toDNA. 1981; 236: 226-231.
18.
Ravirajan C. et al. Antigen binding diversity of human hybridoma autoantibodies derived from splenocytes of patients with SLE. Lupus1992; 1: 167-174.
19.
Jacob L., Tron F., Bach JF, Louvard D.A monoclonal anti-DNA antibody also binds to cell surface proteins. Proc Natl Acad Sci USA1984; 81: 3843-3845.
20.
Naparstek Y. et al. Immunochemical similarities between monoclonal antibacterial Waldenstrom's macroglobulins and monoclonal antiDNA lupus autoantibodies . J Exp Med1985; 161: 1525-1538.
21.
Shoenfeld Y. et al. Production of autoantibodies by human-human hybridomas. J Clin Invest1982; 70: 205-208.
Isenberg DA , Ehrenstein MR, Longhurst C., Kalsi J.The origin, sequence, structure and consequences of developing anti-DNA antibodies - a human perspective. Arthritis Rheum1994; 37: 169-180.
25.
Gilkeson GS , Grudier J., Karounos D., Pisetsky D.Induction of anti-dsDNA antibodies in normal mice by immunization with bacterial DNA. J Immunol1989; 142: 1482-1486.
26.
Gilkeson GS , Bloom DB, Pistesky DS, Clarke SKMolecular characterisation of anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. J Immunol1993; 151: 1353-1364.
27.
Frederiksen K. et al. On the biological origin of anti-double stranded (ds) DNA antibodies: systemic lupus erythematosus-related anti-dsDNA antibodies are induced by polyomavirus BK in lupus-prone (NZB x NZW) F1 hybrids but not in normal mice. Eur J Immunol1994 ; 24: 66-70.
28.
Krishnan MR, Marion TNStructural similarity of antibody variable regions from immune and autoimmune anti-DNA antibodies. J Immunol1993; 150: 4948-4957.
29.
Bell DA, Morrison B., Vanden-Bygaert P.Immunogenic DNA related factors: nucleosomes spontaneously released from normal mouse lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J Clin Invest1990; 85: 1487-1490.
30.
Ehrenstein MR, Longhurst C., Isenberg DAProduction and isotype switching of monoclonal anti-DNA antibodies from SLE patients. Clin Exp Immunol1993; 92: 39-45.
31.
Gordon C., Blount S., Lunec J., Emery P.Measurement of antibodies to human DNA denatured by reactive oxygen species provides a new and more sensitive test for the diagnosis of SLE (abstract) . Br J Rheum1990; 39: S42.
32.
Emlin W., Neibur J., Kadera R.Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol1994; 152: 3685-3692.
33.
Williams W. , Isenberg DAIdiotypes and autologous anti-idiotypes in human autoimmune disease—some theoretical and practical observations . Autoimmunity1994; 17: 343-352.
34.
Theofilipoulos AN, Dixon FJMurine models of systemic lupus erythematosus . Adv Immunol1985; 37: 269-390.
35.
Datta SK et al. Genetic studies of autoimmunity and retrovirus expression in crosses of New Zealand Black mice. I. Xenotropic virus. J Exp Med1978; 147: 854-871.
36.
Andrews B. et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestatins in several strains. J Exp Med1978; 148: 1198-1215.
37.
Schiffenbauer J. et al. A unique sequence of the NZW I-E beta chain and its possible contribution to autoimmunity in the (NZB x NZW) F1 mouse. J Exp Med1989; 170: 971-984.
38.
Cohen PL, Eisenberg RA. lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Ann Rev Immunol1991 ; 9: 243-269.
39.
Bhandoola A. et alg1d and 1pr mice: single gene mutant models for failed self tolerance. Int Rev Immunol1994; 11: 231-244.
40.
Schwartz RHAcquisition of immunolgic self-tolerance. Cell1989; 57: 1079-1081.
41.
Murphy ED, Roths JBAutoimmunity and lymphoproliferation: induction by mutant gene 1pr, and acceleration by male-associated factor in strain BXSB mice. In: Rose NR, Bigazzi PE, Warner NL (eds). Genetic Control of Autoimmune DiseaseElsevier: New York, 1978; pp 207-221.
42.
Cohen PL, Eisenberg RAThe 1pr and g1d genes in systemic autoimmunity: life and death in the Fas lane. Immunol Today1992; 13: 427-428.
43.
Smith CA et al. Antibodies to CD3/T cell receptor complex induce death by apoptosis in immature T cells in thymic culture. Nature1989; 337: 181-184.
44.
Liu Y-J. et al. Mechanism of antigen-driven selection in germinal centres. Nature1989; 342: 929-931.
45.
Kabelitz D. , Phol T., Pechhold K.Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today1993; 14: 338-339.
46.
Von Boehmer HA.The developmental biology of T lymphocytes . Annu Rev Immunol1986; 6: 309-326.
47.
Watanabe-Fukunaga R. et al. The cDNA structure, expression, and chromosal assignment of the mouse Fas antigen. J Immunol1992; 148: 1274-1279.
48.
Drappa J., Brot N., Elkon KBFas protein is expressed at high levels on CD4 + CD8 + thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL-lpr/lpr . Proc Natl Acad Sci USA1993; 90: 10340-10344.
49.
Miyawaki T. et al. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol1992; 149: 3753-3758.
50.
Owen-Schaub LB, Yonehara S., Crump III WI, Grim EADNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol1992; 140: 197-205.
51.
Watanabe-Fukunaga R. et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature1992; 356: 314-317.
52.
Itoh N. et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell1991; 66: 233-243.
53.
Nagata S., Suda T.Fas and Fas ligand: lip and g1d mutations. Immunol Today1995; 16: 39-43.
54.
Ravirajan CT et al. An analysis of apoptosis in lymphoid organs and lupus disease in murine systemic lupus erythematosus. Clin Exp Immunol1996; 105: 306-312.
55.
Steinberg ADConcepts of pathogenesis of systemic lupus erythematosus . Clin Immunol Immunopathol1992; 63: 19-29.
56.
Sobel ES et al. The abnormal 1pr double negative T cell fails to proliferate in vivo. Clin Immunol Immunopathol1995; 74: 177-184.
57.
Van Houten N., Budd RCLessons from the lpr mouse—T lymphocyte development. Seminars in Immunol1994; 6: 1-2.
58.
Steinberg ADMRL-1pr/1pr disease: theories meet Fas. Seminars in Immunol1994; 55-69.
59.
Rozzo SJ, Eisenberg RA, Cohen PL, Kotzin BLDevelopment of the T cell receptorrepertoire in 1pr mice. Seminars in Immunol1994; 6: 19-26.
60.
Ray S., Diamond B.Generation of a fusion partner to sample the repertoire of splenic B cells destined for apoptosis. Proc Natl Acad Sci USA1994; 91: 5548-5551.
61.
Theofilopoulous AN et al. A comparative immunologic analysis of several murine strains with autoimmune manifestations. Clin Immunol Immunopathol1980; 15: 258-278.
62.
Eisenberg RA et al. The role of B cell abnormalities in systemic autoimmune syndromes of lpr and gld mice. Seminars in Immunol1994; 6: 49-54.
63.
Datta SK et al. Pathogenic anti-DNA antibodies and pathogenic autoantibody-inducing T cells. Immunol Ser1991; 55: 133-153.
64.
Wofsy D., Seaman WEReversal of advanced murine lupus in NZB/ NZW F1 mice by treatment with monoclonal antibody to L3T4. J Immunol1987; 138: 3247-3253.
65.
Prud'Home EJ et al. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of lpr/lpr genotype. J Exp Med1983 ; 157: 730-735.
66.
Gavalchin J. , Datta SKThe NZB and SWR model of lupus nephritis. II. Autoantibodies deposited in renal lesions show a distinctive and restricted idiotypic diversity. J Immunol1987; 138: 138-162.
67.
Papoian R., Pillarisetty R., Talal N.Immunological regulation of spontaneous antibodies to DNA and RNA II. Sequential switch from IgM to IgG in NZB/NZWF1 mice. Immunology1974; 32: 75-88.
68.
Datta SK, Patel H., Berry D.Induction cationic shift in IgG anti-DNA antibodies. Role of T helper cells with classical and noval phenotypes in three murine models of lupus nephritis . J Exp Med1987; 165: 1252-1265.
69.
Gallo GR, Caulin-Glaser T., Lamm MECharge of circulating immune complexes as a factor in glomerular basement localization in mice. J Clin Invest1981; 67: 4209-4218.
70.
Stollar BDNucleic acids as antigens. In Sela M (ed). The AntigensAcademic Press: New York, 1973; pp 1-85.
Madaio MP, Hodder S., Schwartz R., Stollar BDResponsiveness of autoimmune and normal mice to nucleic acid antigens. J Immunol1984; 132: 872-876.
73.
Davis P., Russell AS, Percy JSAntibodies to UV light denatured DNA in SLE. J Rheumatol1976; 3: 375-379.
74.
Lafer EM et al. Antibodies specific for left-handed Z-DNA. Proc Nat Acad Sci USA1981; 78: 3546—3550.
75.
Shlomchik MJ et al. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med1990; 171: 265-297.
76.
Rekvig OP et al. Molecular analyses of anti-DNA antibodies induced by polyomavirus BK in BALB/c mice. Scand J Immunol1995; 41: 593—602.
77.
Limpanasithikul W., Ray S., Diamond B.Cross-reactive antibodies have protective and pathogenic and pathogenic potential. J Immunol1995; 155: 967-973.
78.
Stetler DA, Jacob STImmunization of rabbits with purified RNA polymerase I induces a distinct population of antibodies against nucleic acids as well as antipolymerase I antibodies, both characteristics of systemic lupus erythematosus. Proc Natl Acad Sci USA1985; 82: 6779-6789.
79.
Gilkeson GS, Pritchard AJ, Pisetsky DSSpecificity of antiDNA antibodies induced in normal mice by immunization with bacterial DNA. Clin Immunol Immunopath1991 ; 59: 288-300.
80.
Atanassov C. et al. NewZealand white rabbits immunized with RNAcomplexed total histones developed an autoimmune-like response. Clin Exp Immunol1991; 86: 124-133.
81.
Ravirajan CT, Muller S., Katz DR, Isenberg DAEffects of histone and RNA-histone complexes on the disease process of murine SLE. Autoimmunity1995; 21: 117-122.
82.
Desai DD, Krishnan MR, Swindle JT, Marion TNAntigen-specific induction of antibodies against native mammalian DNA in non-autoimmune mice. J Immunol1993; 151: 1614-1626.
Burlingame RW, Rubin RL, Balderas RS, Theofilopoulus ANGenesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest1993; 91: 1687-1696.
85.
Amoura Z. et al. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/ lpr and + / + mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum1994; 37: 1684-1688.
86.
Mohan C., Adams S., Stanik V., Datta SKNucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med1993; 177: 1367-1381.
87.
Ehrenstein MR et al. HumanIgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. Kidney Int1995; 48: 705-711.
88.
Ravirajan CT et al. Genetic, Structural and Functional properties of a human IgG anti-DNA autoantibody. Submitted.
89.
Wu TT, Kabat EAAn analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity . J Exp Med1970; 132: 211—250.
90.
Amzel LM et al. The three-dimensional structure of a combining region-ligand complex of immunoglobulin New at 3.4A resolution. Proc Natl Acad Sci USA1974; 71: 1427-1430.
91.
Herron JN et al. An autoantibody to single-stranded DNA: comparison of the three dimensional structures of the unliganded Fab and a deoxynucleotide-Fav complex . Proteins: Structure, Function and Genetics1991; 11: 159-175.
92.
Tonegawa S.Somatic generation of antibody diversity. Nature1983; 302: 575-581.
93.
Matsuda F. et al. Structure and physical map of 64 variable segments in the 3' 0.8-megabase region of the human immunoglobulin heavy chain locus. Nature Genetics1993; 3: 88-94.
94.
Cook GP et al. A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q. Nature Genetics1994; 7: 162-168.
95.
Waisman A. and Mozes E.Variable region sequences of autoantibodies from mice with experimental systemic lupus erythematosus. Eur J Immunol1993; 23: 1566-1573.
96.
Krishnan MR , Marion TNStructural similarity of antibody variable regions from immune and autoimmune anti-DNA antibodies. J Immunol1993; 150: 4948-4957.
97.
Schlomchik M. et al. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med1990; 171: 265-297.
98.
Foster MH, MacDonald M., Barrett KJ, Madaio MPVH gene analysis of spontaneously activated B cells in adult MRL lpr/lpr mice. J558 bias is not limited to classic lupus antibodies. J Immunol1991; 147: 1504-1511.
99.
Tillman DM, Jou NT, Marion TNBoth IgM and IgG anti-DNA antibody are the products of clonally selective B cell stimulation in (NZB x NZW) F1 mice. J Exp Med1992; 176: 361-380.
100.
Isenberg DA , Ehrenstein MR, Longhurst C., Kalsi JKThe origin, sequence, structure, and consequences of developing anti-DNA antibodies: a human perspective. Arthritis Rheum1994; 37: 169-180.
101.
Winkler TH , Fehr H., Kalden JRAnalysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas. Eur J Immunol1992; 22: 1719-1728.
102.
Paul E., Iliev AA, Livney A., Diamond B.The Anti-DNA Associated Idiotype 8.12 is Encoded by the VyII Gene Family and Maps to the Vicinity of L Chain CDR 1. J Immunol1992; 149: 3588—3593.
103.
Stevenson FK et al. Utilization of the VH4-21 gene segment by antiDNA antibodies from patients with SLE. J Autoimmunity1993; 6: 809-826.
104.
Ehrenstein MR, Longhurst CM, Latchman DS, Isenberg DASerological and genetic characterization of a human monoclonal immunoglobulin G anti-DNA idiotype. J Clin Invest1994; 93: 1787-1797.
Schroeder HW, Hillson JL, Perimutter RMEarly restriction of the human antibody repertoire . Science1987; 238: 791-793.
107.
Schroeder HW and Wang JYPreferntial utilization of conserved immunoglobulin heavy chain variable gene segments during human fetal life. Proc Natl Acad Sci USA1990; 87: 6146-6150.
108.
Dersimonian H., Schwartz RS, Barrett KJ, Stollar BDRelationship of human variable region heavy chain germ-line genes to genes encoding anti-DNA autoantibodies. J Immunol1987; 139: 2496-2501.
109.
Siminovitch KA et al. A human anticardiolipin antibody is encoded by developmentally restricted heavy and light chain variable region genes. Autoimmunity1990; 8: 97-105.
110.
Blanco F. et al. Identification and characterization of a new human DNA reactive monoclonal antibody and a common idiotype, WRI 176 Id β. Lupus1994; 3: 15-24.
111.
Logtenberg T. et al. Autoantibodies encoded by the most JH-proximal human immunoglobulin heavy chain variable region gene. J Exp Med1989; 170: 1347-1355.
Schlomchik MJ et al. The role of clonal selection and somatic mutation in autoimmunity. Nature1987; 328: 805-811.
114.
Stollar D.Molecular analysis of anti-DNA antibodies. FASEB J1994; 8: 337—342.
115.
van Es JH et al. Somatic mutations in the variable region of a human anti-dsDNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus. J Exp Med1991; 173: 461-470.
116.
Huang C., Stollar BDA majority of human IgH chain cDNA of normal human adult blood lymphocytes resembles cDNA for fetal Ig and natural autoantibodies. J Immunol1993; 151: 5290-5300.
117.
Rioux JD, Zdarsky E., Newkirk MM, Rauch J.Anti-DNA and antiplatelet specificities of SLE-derived autoantibodies: evidence for CDR2H mutations and CDR3H motifs. Mol Immunol1995; 32: 683-696.
118.
Manheimer-Lory A. et al. Molecular characteristics of antibodies bearing an anti-DNA associated idiotype. J Exp Med1991; 174: 1639-1652.
119.
Longhurst C. et al. Analysis of immunoglobulin variable genes of a human IgM anti-myeloperoxidase antibody derived from a patient with vasculitis. Immunology1996; 87: 334-338.
120.
Cairns E., Kwong PC, Misener Vip, Bell DAAnalysis of variable region genes encoding a human anti-DNA antibody of normal origin. J Immunol1989; 143: 685—691.
121.
Radic MZ et al. Residues that mediate DNA binding of autoimmune antibodies. J Immunol1993; 150: 4966-4977.
122.
Katz JB, Limpanasithikul W., Diamond B.Mutational analysis of an autoantibody: differential binding and pathogenicity . J Exp Med1994; 180: 925-932.
123.
Pewzner-Jung Y., Simon T., Eilat D.Structural elements controlling anti-DNA antibody affinity and their relationship to anti-phosphorylcholine activity. J Immunol1996; 156: 3065-3973.
124.
Polymenis M., Stollar BDCritical binding site amino acids of anti-Z-DNA single chain Fv molecules: role of heavy and light chain CDR3 and relationship to autoantibody activity. J Immunol1994; 152: 5318-5329.
Putterman C., Limpanasithikul W., Edelman M., Diamond B.The double edged sword of the immune response. Mutational analysis of a murine anti-pneumococcal, anti-DNA antibody. J Clin Invest1996; 97: 2251-2259.
127.
Swanson PC et al. Ligand recognition by murine anti-DNA autoantibodies. II Genetic analysis and pathogenicity. J Clin Invest1996; 97: 1748-1760.
128.
Ohnishi K. et al. Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics. Int Immunol1994; 6: 817-830.
129.
Burlingame RW , Boey ML, Starkebaum G., Rubin RLThe central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest1994; 94: 182-192.
130.
Diamond B. , Scharff MDSomatic mutation of T15 heavy chain gives rise to an antibody with autoantibody specificity. Proc Natl Acad Sci USA1984; 81: 5841-5844.
131.
Amoura Z. et al. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or anti-histone antibodies in serum of MRL-Mp 1pr/ lpr and + / + mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum1994; 37: 1684-1688.
132.
Burlinghame RW, Rubin, RL, Balderas RS, Theopoulos ANGenesis and evolution of anti-chromatin autoantibodies in murine lupus implicates T-dependent immunization with self-antigen. J Clin Invest1993; 91: 1687-1696.
133.
Radic MZ, Weigert M.Genetic and structural evidence for antigen selection of anti-DNA antibodies . Ann Rev Immunol1994; 12: 487-520.
134.
Tomlinson IM et al. The imprint of somatic hypermutation on the repertoire of human germline V genes. J Mol Biol1996; 256: 813-817.
135.
Gibson AL et al. Crystallographic characterization of the Fab fragment of a monoclonal anti ss-DNA antibody. Mol Immunol1985; 22: 499-502.
136.
Cygler M., Boodhoo A., Lee JS, Anderson WFCrystallization and structure detemination ofan autoimmune anti poly(dT) immunoglobulin Fab fragment at 3.0A resolution. JBiol Chem1987; 262: 643—648.
137.
Mol CD et al. Structure of an immunoglobulin Fab Fragment specific for triple-stranded DNA. J Biol Chem1994; 269: 3615-3622.
138.
Mol CD, Muir Aks, Lee JS, Anderson WFStructure of an immunoglobulin Fab Fragment Specific for Poly(dG).Poly(dC) . J Biol Chem1994; 269: 3605—3614.
139.
Martin Acr , Cheetham JC, Rees ARMolecular modelling of antibody combining sites. Meth Enz1991; 203: 121-153.
140.
Chothia C. et al. Conformations of immunoglobulin hypervariable regions. Nature (london)1989; 342: 877—883.
141.
Chothia C. et al. Structural repertoire of human VH segments . J Mol Biol1992; 227: 799-817.
142.
Martin Acr , Cheetham JC, Rees ARModelling antibody hypervariable loops: A combined algorithm. Proc Natl Acad Sci USA1989; 86: 9268—9272.
143.
Kalsi JK et al. Functional and modelling studies of the binding of human monoclonal anti-DNA antibodies to DNA. Mol Immunol1996 ; 33: 471-483.
144.
Stollar BD , Zon G., Parton RWA recognition site on synthetic helical oligonucleotides for monoclonal anti-native DNA autoantibody. Proc Natl Acad Sci USA1986; 83: 4469-4473.
145.
Eagan MA, Norris JM, Cooper BC, Glick GDStructural patterns in anti-DNA autoantibodies: A molecular modelling study . Bioorgan Chem1995; 23: 482-498.
146.
Barry MM, Mol CD, Anderson WF, Lee JSSequencing and modeling of anti-DNA immunoglobulin Fv domains. Comparison with crystal structures. J Biol Chem1994; 269: 3623-3632.